| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DYNAVAX TECHNOLOGIES CORP | 2,472,200 | 59,728,000 | 0.54% | ||
| 52 | SHIRE PLC | 250,971 | 51,449,000 | 0.47% | ||
| 53 | Otonomy Inc | 1,850,094 | 51,340,000 | 0.46% | ||
| 54 | MEDTRONIC PLC | 588,299 | 45,252,000 | 0.41% | ||
| 55 | ARRAY BIOPHARMA INC | 10,689,000 | 45,108,000 | 0.41% | ||
| 56 | CIGNA CORPORATION | 282,000 | 41,265,000 | 0.37% | ||
| 57 | CERUS CORP | 6,504,400 | 41,108,000 | 0.37% | ||
| 58 | VALEANT PHARMACEUTICALS INTL | 390,000 | 39,644,000 | 0.36% | ||
| 59 | NEWLINK GENETICS CORP COM | 955,306 | 34,764,000 | 0.31% | ||
| 60 | INFINITY PHARMACEUTICALS INC | 4,416,300 | 34,668,000 | 0.31% | ||
| 61 | MOLINA HEALTHCARE INC | 568,850 | 34,205,000 | 0.31% | ||
| 62 | AFFIMED N V COM | 4,582,616 | 32,628,000 | 0.30% | ||
| 63 | XENOPORT INC | 5,768,400 | 31,669,000 | 0.29% | ||
| 64 | JOHNSON & JOHNSON | 292,000 | 29,994,000 | 0.27% | ||
| 65 | Sierra Oncology, Inc. | 1,989,949 | 29,929,000 | 0.27% | ||
| 66 | UNITEDHEALTH GROUP INC | 238,000 | 27,998,000 | 0.25% | ||
| 67 | FLUIDIGM CORP DEL COM | 2,449,900 | 26,483,000 | 0.24% | ||
| 68 | CLOVIS ONCOLOGY INC | 729,600 | 25,536,000 | 0.23% | ||
| 69 | GW PHARMACEUTICALS PLC | 304,100 | 21,117,000 | 0.19% | ||
| 70 | ProQR Therapeutics NV | 2,271,500 | 19,717,000 | 0.18% | ||
| 71 | FORWARD PHARMA A/S | 960,600 | 18,251,000 | 0.17% | ||
| 72 | CYNAPSUS THERAPEUTICS INC | 1,140,325 | 17,604,000 | 0.16% | ||
| 73 | STRYKER CORP | 186,000 | 17,287,000 | 0.16% | ||
| 74 | ENANTA PHARMACEUTICALS INC | 504,300 | 16,652,000 | 0.15% | ||
| 75 | Pieris Pharmaceuticals | 7,259,620 | 16,625,000 | 0.15% | ||
| 76 | XENCOR INC COM | 1,107,022 | 16,185,000 | 0.15% | ||
| 77 | BIOMARIN PHARMACEUTICAL INC | 149,000 | 15,609,000 | 0.14% | ||
| 78 | SINOVAC BIOTECH LTD | 2,667,500 | 15,258,000 | 0.14% | ||
| 79 | ZIMMER BIOMET HLDGS INC | 146,800 | 15,060,000 | 0.14% | ||
| 80 | GALAPAGOS NV | 230,000 | 14,462,000 | 0.13% | ||
| 81 | Natera, Inc. | 1,276,190 | 13,783,000 | 0.12% | ||
| 82 | CARDINAL HEALTH INC | 146,000 | 13,033,000 | 0.12% | ||
| 83 | EHEALTH INC COM | 1,300,000 | 12,974,000 | 0.12% | ||
| 84 | SYNERGY PHARMACEUTICALS DEL | 2,276,648 | 12,909,000 | 0.12% | ||
| 85 | ADR - Nabriva Therapeutics AG- Usd | 1,315,000 | 12,650,000 | 0.11% | ||
| 86 | JAZZ PHARMACEUTICALS PLC | 90,000 | 12,650,000 | 0.11% | ||
| 87 | IMMUNOMEDICS INCORPORATED | 3,802,000 | 11,672,000 | 0.11% | ||
| 88 | ENSIGN GROUP INC | 495,200 | 11,206,000 | 0.10% | ||
| 89 | BAXALTA INC COM | 285,000 | 11,124,000 | 0.10% | ||
| 90 | CELLECTIS S A | 350,000 | 10,861,000 | 0.10% | ||
| 91 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 10,492,000 | 0.10% | ||
| 92 | MACROGENICS INC | 317,000 | 9,817,000 | 0.09% | ||
| 93 | ABBOTT LABS | 211,000 | 9,476,000 | 0.09% | ||
| 94 | INCYTE CORP | 4,250,000 | 9,292,000 | 0.08% | PRN | |
| 95 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 9,195,000 | 0.08% | PRN | |
| 96 | VITAE PHARMACEUTICALS INC | 487,400 | 8,822,000 | 0.08% | ||
| 97 | SIENTRA INC | 1,357,500 | 8,036,000 | 0.07% | ||
| 98 | LION BIOTECHNOLOGIES INC COM | 1,022,100 | 7,891,000 | 0.07% | ||
| 99 | MEDIVATION INC | 163,000 | 7,879,000 | 0.07% | ||
| 100 | Marinus Pharmaceuticals Inc | 965,000 | 7,373,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002937, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
